Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Clinical trial NCT00439140 · TERMINATED

Trial details

NCT number: NCT00439140
Sponsor: Allergan
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2007-06-01
Primary completion: 2012-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.